219 related articles for article (PubMed ID: 20353884)
1. Prevalence and molecular mechanism of macrolide resistance in beta-haemolytic streptococci in The Netherlands.
Buter CC; Mouton JW; Klaassen CH; Handgraaf CM; Sunnen S; Melchers WJ; Sturm PD
Int J Antimicrob Agents; 2010 Jun; 35(6):590-2. PubMed ID: 20353884
[TBL] [Abstract][Full Text] [Related]
2. Molecular epidemiology of macrolide resistance in beta-haemolytic streptococci of Lancefield groups A, B, C and G and evidence for a new mef element in group G streptococci that carries allelic variants of mef and msr(D).
Amezaga MR; McKenzie H
J Antimicrob Chemother; 2006 Mar; 57(3):443-9. PubMed ID: 16431859
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and mechanisms of erythromycin and clindamycin resistance in clinical isolates of beta-haemolytic streptococci of Lancefield groups A, B, C and G in Seville, Spain.
Merino Díaz L; Torres Sánchez MJ; Aznar Martín J
Clin Microbiol Infect; 2008 Jan; 14(1):85-7. PubMed ID: 18034859
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).
Tazumi A; Maeda Y; Goldsmith CE; Coulter WA; Mason C; Millar BC; McCalmont M; Rendall J; Elborn JS; Matsuda M; Moore JE
J Antimicrob Chemother; 2009 Sep; 64(3):501-6. PubMed ID: 19584106
[TBL] [Abstract][Full Text] [Related]
5. Low rate of carriage of macrolide-resistant group B streptococci in pregnant women in The Netherlands.
Muller AE; Valkenburg-van den Berg AW; Kreft D; Oostvogel PM; Sprij AJ; van Belkum A
Eur J Obstet Gynecol Reprod Biol; 2008 Mar; 137(1):17-20. PubMed ID: 17482748
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from blood cultures in Korea.
Uh Y; Shin DH; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
J Antimicrob Chemother; 2004 Jun; 53(6):1095-7. PubMed ID: 15117924
[TBL] [Abstract][Full Text] [Related]
7. Macrolide resistance mechanisms and in vitro susceptibility patterns of viridans group streptococci isolated from blood cultures.
Ergin A; Ercis S; Hasçelik G
J Antimicrob Chemother; 2006 Jan; 57(1):139-41. PubMed ID: 16291867
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of resistance to macrolides and lincosamides among staphylococci and streptococci from various animal sources collected in the resistance monitoring program BfT-GermVet.
Lüthje P; Schwarz S
Int J Antimicrob Agents; 2007 May; 29(5):528-35. PubMed ID: 17307339
[TBL] [Abstract][Full Text] [Related]
9. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea.
Uh Y; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
Antimicrob Agents Chemother; 2004 Jul; 48(7):2716-8. PubMed ID: 15215133
[TBL] [Abstract][Full Text] [Related]
11. Macrolide resistance and distribution of erm and mef genes among beta-haemolytic streptococci in Hong Kong.
Ip M; Lyon DJ; Leung T; Cheng AF
Eur J Clin Microbiol Infect Dis; 2002 Mar; 21(3):238-40. PubMed ID: 11957032
[No Abstract] [Full Text] [Related]
12. Inducible clindamycin resistance in β-hemolytic streptococci and Streptococcus pneumoniae.
Megged O; Assous M; Weinberg G; Schlesinger Y
Isr Med Assoc J; 2013 Jan; 15(1):27-30. PubMed ID: 23484235
[TBL] [Abstract][Full Text] [Related]
13. Unusual resistance patterns in macrolide-resistant Streptococcus pyogenes harbouring erm(A).
Malhotra-Kumar S; Mazzariol A; Van Heirstraeten L; Lammens C; de Rijk P; Cornaglia G; Goossens H
J Antimicrob Chemother; 2009 Jan; 63(1):42-6. PubMed ID: 18952616
[TBL] [Abstract][Full Text] [Related]
14. Macrolide resistance determinants of group A streptococci in Ankara, Turkey.
Acikgoz ZC; Gocer S; Tuncer S
J Antimicrob Chemother; 2003 Jul; 52(1):110-2. PubMed ID: 12805256
[TBL] [Abstract][Full Text] [Related]
15. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002.
Farrell DJ; Jenkins SG
J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i17-22. PubMed ID: 15265832
[TBL] [Abstract][Full Text] [Related]
16. [Macrolide resistance phenotypes and genotypes in group G streptococci].
Açikgöz ZC; Göçer S; Almayanlar E
Mikrobiyol Bul; 2003; 37(2-3):117-24. PubMed ID: 14593892
[TBL] [Abstract][Full Text] [Related]
17. [Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
Pathol Biol (Paris); 2004 Oct; 52(8):489-92. PubMed ID: 15465270
[TBL] [Abstract][Full Text] [Related]
18. Clonal diversity among erythromycin-resistant beta-haemolytic Streptococcus isolates in La Rioja, Spain.
Portillo A; Gastañares MJ; Ruiz-Larrea F; Torres C
J Antimicrob Chemother; 2003 Sep; 52(3):485-8. PubMed ID: 12888595
[TBL] [Abstract][Full Text] [Related]
19. Plasmid-Borne erm(T) from invasive, macrolide-resistant Streptococcus pyogenes strains.
Woodbury RL; Klammer KA; Xiong Y; Bailiff T; Glennen A; Bartkus JM; Lynfield R; Van Beneden C; Beall BW;
Antimicrob Agents Chemother; 2008 Mar; 52(3):1140-3. PubMed ID: 18180360
[TBL] [Abstract][Full Text] [Related]
20. Oropharyngeal carriage of macrolide-resistant viridans group streptococci: a prevalence study among healthy adults in Belgium.
Malhotra-Kumar S; Lammens C; Martel A; Mallentjer C; Chapelle S; Verhoeven J; Wijdooghe M; Haesebrouck F; Goossens H
J Antimicrob Chemother; 2004 Feb; 53(2):271-6. PubMed ID: 14729750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
